Publications by authors named "Duezguen Ozatli"

Claim this Profile
C
Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry.
Sema Karakuş, Şule Mine Bakanay, Sevgi Kalayoğlu Beşişik, Ahmet Emre Eşkazan, Orhan Ayyıldız

Turk J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.
Angeliki Meintani, Mustafa Ozdogan, Nikolaos Touroutoglou, Konstantinos Papazisis, Ioannis Boukovinas, Tahsin Ozatli

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Konstantinos Agiannitopoulos, Georgia Pepe, Georgios N Tsaousis, Kevisa Potska, Dimitra Bouzarelou, Tahsin Ozatli

Cancer Genomics Proteomics· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey.
Mehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, Asli Odabası Giden, Istemi Serin, Duzgun Ozatli

J Chemother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report.
Duzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, Serdal Korkmaz, Semih Basci

Transfus Apher Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oscillometric evaluation of the effects of cardiotoxic chemotherapeutic agents on vascular stiffness.
Omer Kertmen, Okan Gulel, Guzin Demirag, Duzgun Ozatli

Blood Press Monit· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions.
Elif Tutku Durmuş, Ayşegül Atmaca, Düzgün Özatlı, Ramis Çolak, Buğra Durmuş

Endocrine· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
Seval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, Omer Ekinci, Ipek Yonal Hindilerden, Duzgun Ozatli

Clin Lymphoma Myeloma Leuk· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis in patients with sepsis: A multicenter retrospective study.
Kaniye Aydin, Serdal Korkmaz, Mehmet Ali Erkurt, Ahmet Sarici, Omer Ekinci, Duzgun Ozatli

Transfus Apher Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive tumor molecular profile analysis in clinical practice.
Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, Aikaterini Tsantikidi, Vasiliki-Metaxa Mariatou

BMC Med Genomics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective response rate assessment in oncology: Current situation and future expectations.
Nuri Faruk Aykan, Tahsin Özatlı

World J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.
Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, Ali Eser, Tayfur Toptaş

Turk J Haematol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Turkish experience with therapeutic plasma exchange: A national survey.
Serdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, Sevgi Kalayoglu Besisik, Senem Altay Dadin, Duzgun Ozatli

Transfus Apher Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.
Onur Esbah, Umut Demirci, Kaan Helvaci, Fatma Paksoy Turkoz, Ahmet Siyar Ekinci, Tahsin Ozatli

J BUON· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Fluorescent In Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey.
Ümmet Abur, Gönül Oğur, Ömer Salih Akar, Engin Altundağ, Huri Sema Aymelek

Turk J Haematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik

Balkan Med J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Ahmet Siyar Ekinci, Umut Demirci, Berna Cakmak Oksuzoglu, Ayse Ozturk, Onur Esbah, Tahsin Ozatli

J BUON· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun U Unal, Ilhan Oztop, Ozan Yazici, Tahsin Ozatli, Ali Inal

Oncol Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun Umit Unal, Ilhan Oztop, Nurgul Yasar, Zuhat Urakci, Tahsin Ozatli

Thorac Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of T helper-2 pathway components interleukin-4, interleukin-10, immunoglobulin e, and eosinophils with prognostic markers in non-hodgkin lymphoma: a case-control study.
Nil Güler, Engin Kelkitli, Hilmi Atay, Dilek Erdem, Hasan Alaçam

Turk J Haematol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Mehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, Ozan Yazıcı, Sercan Aksoy

Med Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio.
Engin Kelkitli, Hilmi Atay, Fatih Cilingir, Nil Güler, Yüksel Terzi

Ann Hematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric carcinoma with bone marrow metastasis: a case series.
Ahmet Şiyar Ekinci, Oznur Bal, Tahsin Ozatlı, Ibrahim Türker, Onur Eşbah

J Gastric Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.
M Hilmi Atay, Duzgun Ozatli, Engin Kelkitli, Levent Yildiz, Mehmet Turgut

Histopathology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[In Vitro Effect of Ankaferd Blood Stopper®, a Plant Extract Against Mycobacterium tuberculosis Isolates].
Aydın Deveci, Ahmet Yılmaz Coban, Yeliz Tanrıverdi Çaycı, Ozlem Acicbe, Nuriye Taşdelen Fışgın

Mikrobiyol Bul· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis